Louisville Metabolic and Atherosclerosis Research Center (L-MARC) — Louisville, Kentucky

Louisville Metabolic and Atherosclerosis Research Center (L-MARC) is a clinical research site located in Louisville, Kentucky, United States 40213.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Louisville Metabolic and Atherosclerosis Research Center (L-MARC) has participated in 13 clinical trials with 3 currently active.

Therapeutic areas: Dyslipidemia, Obesity, Overweight.

Sponsors: Pronova BioPharma, Carmot Therapeutics, Inc., Elcelyx Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Louisville Metabolic and Atherosclerosis Research Center (L-MARC)?

Louisville Metabolic and Atherosclerosis Research Center (L-MARC) has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Louisville Metabolic and Atherosclerosis Research Center (L-MARC) conducted?

Louisville Metabolic and Atherosclerosis Research Center (L-MARC) has 13 clinical trials on record, with 3 currently active. Their work covers Dyslipidemia, Obesity, Overweight.

Is Louisville Metabolic and Atherosclerosis Research Center (L-MARC) accredited by Crixeo Health?

Yes — Louisville Metabolic and Atherosclerosis Research Center (L-MARC) holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Louisville Metabolic and Atherosclerosis Research Center (L-MARC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.